SEC Form 4 · accession 0001209191-17-038788
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mario Settino
Officer — Chief Financial Officer
Period of report
Jun 1, 2017
Accepted (ET)
Jun 9, 2017 · 2:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.07 | Jun 1, 2017 | A | 200,000 | A | — | May 14, 2027 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Vesting as follows: twenty-five percent (25%) vesting on May 15, 2018, and the remaining seventy-five percent (75%) vesting on a monthly basis over the three (3) following years.